with financial results like this... this company drugs come out way too late to make a dollars... they keep reinventing the wheel by blowing share holders money... better of developing a totally new drug which doesn't exists... At least directors got paid well for the company losses...
A investor needs a lot of hope or luck to hold this stock after 4 straight years of losses
Group Performance
(Loss) before tax ($’000) :
2017 (94)
2018 (16,125)
2019 (8,335)
2020 (9,385)
Add to My Watchlist
What is My Watchlist?
